ArticleMolecular and cellular biochemistry2026
Nuclear factor I-C as a novel candidate regulator in postoperative atrial fibrillation: integrated omics and proof-of-concept validation.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Postoperative atrial fibrillation (POAF) is a frequent complication of cardiac surgery, yet the upstream transcriptional regulators driving the pro-arrhythmic substrate remain unexplored. We aimed to identify and validate key transcription factors associated with POAF susceptibility. We performed cross-cohort integration of two independent human atrial transcriptomic datasets and applied machine learning (LASSO and SVM-RFE) to prioritize candidate genes. Transcriptional targets were predicted using the TRRUST database and protein-protein interaction (PPI) network analysis. Cellular localization was resolved using murine atrial scRNA-seq data. In vivo functional validation and biochemical signaling assays were performed in a spontaneous POAF (sPOAF) mouse model using AAV9-mediated NFIC overexpression. Nuclear Factor I-C (NFIC) was identified as a robust candidate regulator, showing consistent downregulation in human POAF cohorts and sPOAF mice. By intersecting predicted NFIC targets with the PI3K/Akt pathway, hepatocyte growth factor (HGF) was nominated as a putative downstream effector. Single-cell profiling localized NFIC and HGF predominantly to the atrial fibroblast lineage, where both were significantly downregulated in POAF. In the sPOAF model, p-AKT/AKT ratios were significantly reduced during the acute postoperative phase. Critically, AAV9-mediated NFIC restoration significantly decreased POAF incidence by 50%. Our findings identify NFIC as a novel candidate transcriptional regulator associated with POAF. These data support a working model involving a fibroblast-centered NFIC-HGF-PI3K/AKT axis, providing a fresh framework for understanding the upstream control of the postoperative atrial microenvironment.
Indexed as
Identifiers
42048026What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.